HYPOKALAEMIA

✓ Medically ReviewedDISEASEID: MDBT0087🚨 TRIAGE: URGENTICD-10: E87.6

📖

Definition

CLINICAL DEFINITION

Hypokalaemia is serum potassium below 3.5 mmol per L. It reflects true deficit or shift into cells (movement from blood into cells). It impairs muscle, nerve and cardiac function (systems for movement and heartbeat). Severe cases cause arrhythmia (abnormal heart rhythm) and weakness. Diagnosis needs laboratory confirmation (blood test result) with clinical context.

IN PLAIN ENGLISH

Potassium is a mineral that helps muscle and heart work. Low level means below normal on a blood test. It can cause cramps, weakness or fluttery heartbeat. Common triggers are vomiting, diarrhoea and water tablets. Treatment replaces potassium and fixes the cause.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Hypokalaemia is not low sodium or low calcium (different minerals in blood). It is not hyperkalaemia (high potassium, the opposite problem). It is not pseudohypokalaemia (falsely low result from sample handling) without true deficit. It does not alone define one single disease (such as kidney failure). It is a laboratory abnormality (blood test finding) needing cause assessment.

🔤

Word Breakdown

hypo-

=low or below normal

kali-

=potassium from kalium, term for alkali mineral

-aemia

=in blood, British spelling of blood condition

Literal Meaning: low potassium in blood

🏷️

Abbreviations

K+=Potassium ion, the charged mineral measured to define this condition

S-K+=Serum potassium, the laboratory measurement of potassium in blood serum

🔄

Synonyms & Variants

Hypokalemia›Low serum potassium›Kaliopenia›

🎯

Category-Specific Context

Hypokalaemia is classed as Disease because it is a pathological electrolyte disorder (abnormal body chemistry). It is not only a symptom (patient reported problem) or sign (examination finding). It has defined thresholds, causes and treatments. It links to renal (kidney), endocrine (hormone) and gut disease.

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Emergency DepartmentGeneral PracticeAcute Medical WardIntensive Care UnitCardiology ClinicNephrology Clinic

USAGE & DOCUMENTATION NOTES

Use hypokalaemia for confirmed low serum potassium (blood potassium below range). Document severity, symptoms and ECG (heart tracing) findings. State suspected cause and drugs (medicines that waste potassium). Do not use it for low intake alone without low blood level.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Potassium is mainly inside cells (body cells hold most potassium). Serum level depends on intake, shifts and renal loss (kidney excretion). Aldosterone (salt retaining hormone) increases kidney potassium wasting. Alkalosis (high blood pH) and insulin (blood sugar hormone) drive potassium into cells. Low magnesium (partner mineral) prevents kidney retention of potassium. Net effect is reduced excitability threshold (change in muscle and heart firing) with weakness and arrhythmia (abnormal rhythm).

PRIMARY CAUSES

Vomiting and nasogastric suction

Loss of acid causes metabolic alkalosis (high blood pH) and volume loss activates aldosterone (salt retaining hormone) which drives kidney potassium wasting

Diarrhoea and laxative misuse

Direct faecal potassium loss depletes stores and volume depletion (low body fluid) triggers aldosterone (salt retaining hormone) with further renal loss

Primary aldosteronism and secondary hyperaldosteronism

Excess aldosterone (salt retaining hormone) increases distal sodium reabsorption (salt uptake in kidney tubule) in exchange for potassium secretion into urine

Renal tubular disorders including Bartter and Gitelman syndromes

Inherited salt handling defects (faulty kidney tubule transport) increase distal flow and aldosterone drive (hormone signal) causing chronic potassium wasting

Hypomagnesaemia

Low magnesium (partner mineral) impairs ROMK channel regulation (potassium channel control in kidney) and prevents conservation, so potassium is lost despite replacement

Alkalosis, insulin rise and catecholamine surge

High pH and insulin (blood sugar hormone) plus adrenaline (stress hormone) activate Na-K ATPase (cell pump that moves potassium inward) shifting potassium into cells without total loss

Poor intake with chronic illness and alcohol use

Inadequate dietary potassium (low fruit and salt intake) combined with gut and kidney losses depletes the small extracellular pool (potassium outside cells) over time

💊

Drug-Induced Causes

💊 Thiazide diuretics (bendroflumethiazide, indapamide, hydrochlorothiazide) ↗

Mechanism: Block distal sodium reabsorption (salt uptake in early distal tubule) increasing delivery downstream where aldosterone (salt retaining hormone) exchanges sodium for potassium loss

→ Check potassium and magnesium (partner mineral) within weeks of start, supplement potassium, consider dose reduction or potassium sparing agent on specialist advice

💊 Loop diuretics (furosemide, bumetanide, torasemide) ↗

Mechanism: Inhibit NKCC2 in thick ascending limb (salt transporter in kidney loop) causing volume loss (low body fluid) and high distal flow that drives potassium secretion

→ Monitor electrolytes and renal function (kidney blood tests), replace potassium and magnesium, review volume status and indication

💊 Corticosteroids and mineralocorticoids (prednisolone, hydrocortisone, fludrocortisone) ↗

Mechanism: Glucocorticoid excess with mineralocorticoid activity (salt retaining effect) enhances collecting duct sodium uptake (salt absorption in final tubule) with potassium excretion

→ Use lowest effective dose for shortest time (smallest dose for brief period), monitor potassium, supplement if low and arrange taper plan

💊 Beta-2 agonists (salbutamol, terbutaline) and insulin ↗

Mechanism: Stimulate Na-K ATPase (cell pump that moves potassium inward) shifting potassium into cells (movement from blood into cells) causing transient fall without total deficit

→ Recheck after acute effect resolves (repeat blood test when drug wears off), monitor ECG (heart tracing) and supplement only if truly low

💊 Amphotericin B ↗

Mechanism: Direct tubular toxicity (kidney tubule injury) causes renal wasting of potassium and magnesium (loss in urine despite low blood levels)

→ Monitor potassium and magnesium closely (frequent blood checks), give high dose replacement and seek renal or infection specialist input for formulation change

🌍

Epidemiology

Prevalence:Hypokalaemia is common in hospital practice (care of admitted patients). It is frequent with diuretics (water tablets), vomiting and diarrhoea (gut losses). It is seen in hypertension clinics (high blood pressure services) with aldosterone excess (salt hormone excess). Risk rises with loop and thiazide use (types of water tablets).

Age Group:Hypokalaemia occurs at all ages (from children to older adults). Risk is higher in older adults on diuretics (water tablets for blood pressure). Young cases suggest tubular disorders (kidney salt handling faults) or eating disorders (disordered nutrition with vomiting).

Geographic Distribution:Hypokalaemia occurs worldwide (in all health systems). It is more visible where diarrhoeal illness (gut infection with loose stools) is common. It clusters where thiazide prescribing (water tablet use) is widespread. No strong endemic focus (local geographic hotspot) is described.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 URGENT

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Thyrotoxic Periodic Paralysis with rebound hyperkalaemia (thyroid driven shift)
Primary Aldosteronism with hypertension (salt hormone tumour)
Gitelman or Bartter Syndrome in young recurrent cases (inherited kidney salt loss)
Magnesium Depletion preventing correction (partner mineral deficit)
Digoxin Toxicity precipitated by low potassium (heart drug harm)

URGENT EVALUATION TRIGGERS

ECG changes including U waves, ST depression or arrhythmia (heart tracing danger signs)
Severe weakness, paralysis or respiratory difficulty (muscle failure signs)
Potassium below 2.5 mmol per L or rapid fall (critical threshold)
Ongoing vomiting, diarrhoea or diuretic loss (active potassium wasting)
Symptomatic palpitations or syncope (faint with rhythm concern)

Contraindications & Precautions

CONTRAINDICATIONS

Do not give potassium supplements when hyperkalaemia (high potassium) is present
Do not give potassium without renal assessment (kidney function check) in oliguria (very low urine output)
Do not give rapid intravenous potassium push (fast vein injection) outside monitored setting
Do not correct without checking magnesium (partner mineral) when replacement fails

SPECIAL PRECAUTIONS

Monitor ECG (heart tracing) and rhythm during replacement
Monitor renal function and urine output (kidney checks) during therapy
Recheck potassium and magnesium (blood minerals) after each correction step
Use cardiac monitoring (heart rhythm watch) for severe cases or intravenous replacement
Review drugs and acid base status (medicines and blood pH) before discharge

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Cardiac arrhythmia with QT prolongation and U waves (heart tracing changes that predict rhythm risk)
Muscle weakness and ascending paralysis (limb heaviness progressing upward)
Rhabdomyolysis (muscle breakdown releasing harmful proteins)
Ileus and constipation (gut standstill with bloating)
Respiratory muscle failure (breathing weakness needing support)
Digoxin toxicity potentiation (heart drug harm at low potassium)

📏

Reference Ranges

NORMAL RANGE3.5 to 5.0 mmol per L, with some laboratories using up to 5.3 mmol per L as upper limit

CRITICAL (PANIC) VALUEBelow 2.5 mmol per L is severe and critical, while below 3.0 mmol per L with ECG changes or weakness needs emergency care

UNIT OF MEASUREMENTmmol/L

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Hyperkalaemia

Names differ by one prefix (hypo meaning low versus hyper meaning high) and both concern potassium (blood mineral), while hyperkalaemia is high potassium with peaked T waves (tall heart tracing spikes) not low potassium

Hypocalcaemia

Shares hypo and aemia endings (low and blood pattern) causing visual confusion, while hypocalcaemia is low calcium (different mineral for bones and nerves) with tetany (muscle spasms) not low potassium

Hyponatraemia

Looks similar with hypo and aemia structure (low and blood pattern) and both are electrolytes (blood salts), while hyponatraemia is low sodium (salt mineral) with confusion and seizures (fits) not potassium loss

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Hyperkalaemia

Key Distinguishing Feature: High potassium above 5.0 mmol per L with peaked T waves (tall heart tracing spikes) versus low potassium with U waves (extra heart tracing bumps) and flat T waves

Hypomagnesaemia

Key Distinguishing Feature: Low magnesium often coexists (partner mineral deficit) but primary ion is magnesium (different mineral) with tetany (muscle spasms) and refractory potassium loss until magnesium is fixed

Pseudohypokalaemia

Key Distinguishing Feature: Falsely low result from delayed analysis or leucocytosis (high white cells taking up potassium in tube) with normal repeat on rapid handling (quick lab processing) and no ECG changes

Thyrotoxic periodic paralysis

Key Distinguishing Feature: Acute flaccid weakness (sudden limp muscle failure) with thyrotoxicosis (overactive thyroid with tremor and heat intolerance) and intracellular shift (movement into cells) that reverses with thyroid control

💎

Clinical Pearls

💎

Always check magnesium in hypokalaemia because low magnesium (partner mineral deficit) blocks correction and must be replaced together.

💎

Look at the ECG in every case because U waves, flat T waves and long QT (heart tracing markers) reveal cardiac risk even with modest falls.

💎

Measure urine potassium and acid base status (urine loss check and blood pH) to separate renal wasting (kidney loss) from gut loss and shifts.

💎

Review diuretics and laxatives first because thiazides and loops (water tablets) are the most common reversible drivers in practice.

💎

Replace promptly when below 3.0 mmol per L with ECG changes or below 2.5 mmol per L even if well, with cardiac monitoring and frequent rechecks.

📝

Example Usage & SOAP

CLINICAL SENTENCE

""68-year-old on indapamide presented with cramps and palpitations and potassium 2.9.""

IN A SOAP NOTE

S: 68-year-old with cramps, fatigue and palpitations on thiazide. No chest pain, no diarrhoea, no vomiting. O: BP 134/82, HR 96 irregular, RR 18, SpO2 98 percent on air, Temp 36.7C. ECG shows U waves and flat T waves. Labs: K 2.8 mmol per L, Mg low. A: Moderate hypokalaemia with ECG changes, likely diuretic related. P: Cardiac monitoring, oral potassium plus magnesium, hold thiazide, recheck in 4 to 6 hours, investigate aldosterone if recurrent.

DIFFERENTIAL DIAGNOSIS CONTEXT

A patient with weakness and U waves could have hypokalaemia from diuretics (water tablet loss) versus thyrotoxic periodic paralysis (thyroid driven shift) versus Gitelman syndrome (inherited kidney salt loss). Urine potassium, thyroid tests (neck hormone checks) and magnesium separate renal wasting (kidney loss) from shifts and gut loss.

📈

Prognosis

SHORT-TERM OUTCOME

Short term outcome depends on severity and cardiac status (heart rhythm stability). Mild cases recover quickly with replacement (potassium given by mouth or vein). Severe cases risk arrhythmia (abnormal rhythm) and respiratory weakness (breathing muscle failure). Prompt correction and monitoring (ECG and blood checks) improve safety.

LONG-TERM PROGNOSIS

Long term outlook depends on underlying cause (disease driving the loss). Reversible causes have excellent prognosis (full recovery expected). Chronic aldosteronism or tubular disease (long term kidney or hormone faults) needs ongoing care. Recurrence is common without cause control (continued wasting) and magnesium correction (partner mineral replacement).

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

E87.6

LITERATURE CITATIONS & GUIDELINES

[1]WHO ICD-10 E87.6 Hypokalaemia

[2]Harrisons Principles of Internal Medicine

[3]Davidsons Principles and Practice of Medicine

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.